logo
12:04 Apr 30

Concord Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
1541.20
-16.60 (-1.07%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
1541.20
-16.60 (-1.07%)
12:04 Apr 30
Quality
image/svg+xml

75/100
High Financial Strength

Valuation
image/svg+xml

15/100
Expensive Valuation

Technical

32/100
Technically Bearish

Strength

8

Weakness

6

Opportunity

1

Threats

0

20.18 %

ROE %

18.11 %

ROA %

31.19

EPS

145.93

BVPS

30.29 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
712.93 853.17 1016.94 1089.17
Operating Expenses +
439.66 509.88 585.39 638.97
Raw Material
187.99 195.84 241.28 296.83
Increase Decrease in Cost
-23.98 -15.63 -12.08 -30.97
Other Manufacturing Expense
0 0 0 26.44
Employee Cost
95.69 110.28 123.05 133.92
Miscellaneous Expenses
241.42 276.93 346.62 212.75
Operating Profit
273.27 343.29 431.55 450.2
Other Income
23.42 35.31 33.78 45.88
Depreciation
50.05 54.03 53.59 53.47
Interest
5.48 4.51 2.55 0.9
Profit before tax and exceptio..
241.16 320.05 409.19 441.71
Exceptional Items
0 0 0 0
PBT
241.16 320.05 409.19 441.71
Provision for Taxation
62.59 81.93 104.46 113.45
Net Profit
178.57 238.13 304.73 328.24
NET Profit after MI
174.93 240.09 308.1 326.27
EPS
16.72 22.95 29.45 31.19
Operating Profit Margin (%)
38.33 40.24 42.44 41.33
Net Profit Margin (%)
24.54 28.14 30.3 29.96

ShareHolding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 44.10 44.10 44.10 44.10 44.10
FII 9.40 8.30 8.10 7.10 6.50
MF 5.20 4.90 5.00 5.30 5.20
Public 37.40 37.90 38.00 38.40 41.00
Others 0.00 0.00 0.00 0.00 0.00
Others 3.90 4.80 4.80 5.10 3.20
Shareholder Shares Holding %
Research 360 logo

Download Our App On: